These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35536611)

  • 21. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
    Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
    J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and
    Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP
    ACS Chem Neurosci; 2020 Dec; 11(24):4434-4446. PubMed ID: 33253529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.
    Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF
    J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GC-MS/MS analysis of synthetic cannabinoids 5F-MDMB-PICA and 5F-CUMYL-PICA in forensic cases.
    Ahmed H; Mujeebuddin S
    Bioanalysis; 2024; 16(9):401-413. PubMed ID: 38466892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatal intoxication by 5F-ADB and diphenidine: Detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q-TOFMS.
    Kusano M; Zaitsu K; Taki K; Hisatsune K; Nakajima J; Moriyasu T; Asano T; Hayashi Y; Tsuchihashi H; Ishii A
    Drug Test Anal; 2018 Feb; 10(2):284-293. PubMed ID: 28544560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA.
    Wohlfarth A; Castaneto MS; Zhu M; Pang S; Scheidweiler KB; Kronstrand R; Huestis MA
    AAPS J; 2015 May; 17(3):660-77. PubMed ID: 25721194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A simple and robust method for broad range screening of hair samples for drugs of abuse using a high-throughput UHPLC-Ion Trap MS instrument.
    Musile G; Mazzola M; Shestakova K; Savchuk S; Appolonova S; Tagliaro F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122263. PubMed ID: 32693369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry.
    Presley BC; Logan BK; Jansen-Varnum SA
    Drug Test Anal; 2019 Aug; 11(8):1264-1276. PubMed ID: 31108568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schedules of Controlled Substances: Placement of PB-22, 5F-PB-22, AB-FUBINACA and ADB-PINACA into Schedule I. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Sep; 81(172):61130-3. PubMed ID: 27632803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro metabolism of the synthetic cannabinoids PX-1, PX-2, and PX-3 by high-resolution mass spectrometry and their clearance rates in human liver microsomes.
    Cooman T; Bell S
    Rapid Commun Mass Spectrom; 2019 Dec; 33(23):1816-1825. PubMed ID: 31364227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enantiospecific Synthesis, Chiral Separation, and Biological Activity of Four Indazole-3-Carboxamide-Type Synthetic Cannabinoid Receptor Agonists and Their Detection in Seized Drug Samples.
    Antonides LH; Cannaert A; Norman C; Vives L; Harrison A; Costello A; Nic Daeid N; Stove CP; Sutcliffe OB; McKenzie C
    Front Chem; 2019; 7():321. PubMed ID: 31157203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018.
    Ong RS; Kappatos DC; Russell SGG; Poulsen HA; Banister SD; Gerona RR; Glass M; Johnson CS; McCarthy MJ
    Drug Test Anal; 2020 Feb; 12(2):195-214. PubMed ID: 31595682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging Synthetic Cannabinoids: Development and Validation of a Novel Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry Assay for Real-Time Detection.
    Krotulski AJ; Mohr ALA; Logan BK
    J Anal Toxicol; 2020 Apr; 44(3):207-217. PubMed ID: 31909808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.
    Mogler L; Franz F; Wilde M; Huppertz LM; Halter S; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Sep; 10(9):1417-1429. PubMed ID: 29726116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisons.
    Kronstrand R; Norman C; Vikingsson S; Biemans A; Valencia Crespo B; Edwards D; Fletcher D; Gilbert N; Persson M; Reid R; Semenova O; Al Teneiji F; Wu X; Dahlén J; NicDaéid N; Tarbah F; Sutcliffe OB; McKenzie C; Gréen H
    Drug Test Anal; 2022 Apr; 14(4):634-652. PubMed ID: 34811926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of three cannabimimetic indazole and pyrazole derivatives, APINACA 2H-indazole analogue, AMPPPCA, and 5F-AMPPPCA.
    Jia W; Meng X; Qian Z; Hua Z; Li T; Liu C
    Drug Test Anal; 2017 Feb; 9(2):248-255. PubMed ID: 26968728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
    Franz F; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 2-alkyl-2
    Longworth M; Banister SD; Mack JBC; Glass M; Connor M; Kassiou M
    Forensic Toxicol; 2016; 34():286-303. PubMed ID: 27547266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of three novel new psychoactive substances 4F-AB-BUTINACA, AB-PHETINACA, and 2F-NENDCK.
    Wang KD; Yuan XL; Liu C; Cao FQ; Zhang YR; Liu WB; He SY
    Drug Test Anal; 2023 Jan; 15(1):115-122. PubMed ID: 35986510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2014 Feb; 79(27):7577-82. PubMed ID: 24605391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.